Margherita Muratore
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.
Journal: Critical reviews in oncology/hematology
Published: March 26, 2024
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Journal: Frontiers in oncology
Published: January 27, 2023
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.
Journal: Frontiers in oncology
Published: September 24, 2022
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: August 30, 2022
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making.
Journal: Cancers
Published: July 31, 2022
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.
Journal: Frontiers in oncology
Published: October 18, 2021
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer.
Journal: Expert opinion on emerging drugs
Published: October 12, 2020
Immunotherapy in gynecological cancers.
Journal: Exploration of targeted anti-tumor therapy
Published: July 29, 2020
Newly diagnosed ovarian cancer: Which first-line treatment?
Journal: Cancer treatment reviews
Published: July 21, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026